Kreitzer Anatol (CIK 2021238) reported 15 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-19). Recent activity: Buy MPLT (6,020 shares), Sell MPLT (5,545 shares), Sell MPLT (4,510 shares), Sell MPLT (7,464 shares), Sell MPLT (1,592 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-19 | MapLight Therapeutics, Inc. (MPLT) | Chief Discovery Officer | Buy | 6,020 | $0 |
| 2026-07-20 | MapLight Therapeutics, Inc. (MPLT) | Chief Discovery Officer | Sell | 5,545 | $200,341 |
| 2026-07-20 | MapLight Therapeutics, Inc. (MPLT) | Chief Discovery Officer | Sell | 4,510 | $166,599 |
| 2026-07-20 | MapLight Therapeutics, Inc. (MPLT) | Chief Discovery Officer | Sell | 7,464 | $273,630 |
| 2026-07-20 | MapLight Therapeutics, Inc. (MPLT) | Chief Discovery Officer | Sell | 1,592 | $59,604 |
| 2026-07-20 | MapLight Therapeutics, Inc. (MPLT) | Chief Discovery Officer | Sell | 2,833 | $104,963 |
| 2026-07-20 | MapLight Therapeutics, Inc. (MPLT) | Chief Discovery Officer | Sell | 14,140 | $533,078 |
| 2026-07-20 | MapLight Therapeutics, Inc. (MPLT) | Chief Discovery Officer | Sell | 200 | $7,678 |
| 2026-04-29 | MapLight Therapeutics, Inc. (MPLT) | Chief Discovery Officer | Sell | 8,346 | $241,700 |
| 2026-04-29 | MapLight Therapeutics, Inc. (MPLT) | Chief Discovery Officer | Sell | 29,255 | $866,826 |
| 2026-04-29 | MapLight Therapeutics, Inc. (MPLT) | Chief Discovery Officer | Sell | 7,821 | $238,540 |
| 2026-04-17 | MapLight Therapeutics, Inc. (MPLT) | Chief Discovery Officer | Sell | 3,316 | $88,239 |
| 2026-02-09 | MapLight Therapeutics, Inc. (MPLT) | Chief Discovery Officer | Buy | 6,020 | $0 |
| 2026-01-29 | MapLight Therapeutics, Inc. (MPLT) | Chief Discovery Officer | Sell | 42,099 | $756,940 |
| 2025-10-28 | MapLight Therapeutics, Inc. (MPLT) | Chief Discovery Officer | Buy | 35,953 | $0 |
Source: SEC Form 4 filings · as of 2026-08-19